Liver Cirrhosis Research Today is a free monthly online journal that collates and summarizes the latest research about Liver Cirrhosis, including details on alcohol, treatment, drugs, effects, causes.

Volume 4 (2007), Issue 8 (August)

1. Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis.
   Hepatology, 46(2): 590-7. [Abstract] [Full-text]
2. Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis.
   Hepatology, 46(2): 456-62. [Abstract] [Full-text]
3. The international normalized ratio calibrated for cirrhosis (INR(liver)) normalizes prothrombin time results for model for end-stage liver disease calculation.
   Hepatology, 46(2): 520-7. [Abstract] [Full-text]
4. Simple blood tests as noninvasive markers of liver fibrosis in hemodialysis patients with chronic hepatitis C virus infection.
   Hepatology, 46(2): 307-14. [Abstract] [Full-text]
5. Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis.
   Hepatology, 46(2): 388-94. [Abstract] [Full-text]
6. A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C.
   Hepatology, 46(2): 297-306. [Abstract] [Full-text]
7. Increased age, male gender, and cirrhosis, but not steatosis or a positive viral serology, negatively impact the life expectancy of patients who undergo liver biopsy.
   Dig Dis Sci, 52(9): 2276-81. [Abstract] [Full-text]
8. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.
   Transplantation, 84(3): 331-9. [Abstract] [Full-text]
9. MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation.
   Gut, 56(9): 1283-90. [Abstract] [Full-text]
10. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.
    Gut, 56(9): 1296-301. [Abstract] [Full-text]
11. Elevation of endoglin (CD105) concentrations in serum of patients with liver cirrhosis and carcinoma.
    Eur J Gastroenterol Hepatol, 19(9): 755-61. [Abstract] [Full-text]
12. Peri-operative respiratory failure in a cirrhotic patient: a misleading diagnosis.
    Anaesthesia, 62(9): 963-5. [Abstract] [Full-text]
13. Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages.
    Clin Chem, 53(9): 1615-22. [Abstract] [Full-text]
14. Liver volume variation in patients with virus-induced cirrhosis: findings on MDCT.
    AJR Am J Roentgenol, 189(3): W153-9. [Abstract] [Full-text]
15. The mechanism of how anti-IL-18 prevents concanavalin-A-induced hepatic fibrosis on a mouse model.
    J Surg Res, 142(1): 175-83. [Abstract] [Full-text]
16. Effects of biphenyldimethyl-dicarboxylate administration alone or combined with silymarin in the CCL4 model of liver fibrosis in rats.
    ScientificWorldJournal, 7: 1242-55. [Abstract] [Full-text]
17. Bile duct dysplasia in the setting of chronic hepatitis C and alcohol cirrhosis.
    Am J Surg Pathol, 31(9): 1410-3. [Abstract] [Full-text]
18. Effect of the CYP2E1 genotype on vinyl chloride monomer-induced liver fibrosis among polyvinyl chloride workers.
    Toxicology, 239(1): 34-44. [Abstract] [Full-text]
19. Management in patients with liver cirrhosis and an umbilical hernia.
    Surgery, 142(3): 372-5. [Abstract] [Full-text]
20. Altered gene expression profiles in the frontal cortex of cirrhotic alcoholics.
    Alcohol Clin Exp Res, 31(9): 1460-6. [Abstract] [Full-text]
21. Elevated serum levels of interferon- gamma -inducible protein-10 in patients coinfected with hepatitis C virus and HIV.
    J Infect Dis, 196(7): 1053-7. [Abstract] [Full-text]

© 2004-2008 Liver Cirrhosis Research Today. All Rights Reserved.